13F
中

DXCM DEXCOM INC

2026Q1 · CUSIP 252131107 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
954
Δ holders QoQ
+34
Breadth percentile
Top 8%
Whale holders
300
Δ whales
-5
Inst. holding value
$22.5B
New positions
148
Closed positions
114
Price momentum (1Q)
-7.6%
Put / Call
26/23

Breadth history (34 quarters)

2018Q1: Δ+5 · h=277 2018Q2: Δ+13 · h=290 2018Q3: Δ+71 · h=361 2018Q4: Δ+54 · h=415 2019Q1: Δ+39 · h=454 2019Q2: Δ-36 · h=418 2019Q3: Δ+8 · h=426 2019Q4: Δ+84 · h=510 2020Q1: Δ+82 · h=592 2020Q2: Δ+126 · h=718 2020Q3: Δ+9 · h=727 2020Q4: Δ+5 · h=732 2021Q1: Δ-2 · h=730 2021Q2: Δ-7 · h=723 2021Q3: Δ+72 · h=795 2021Q4: Δ+137 · h=932 2022Q1: Δ-72 · h=860 2022Q2: Δ-62 · h=798 2022Q3: Δ-6 · h=792 2022Q4: Δ+126 · h=918 2023Q1: Δ-14 · h=904 2023Q2: Δ+48 · h=952 2023Q3: Δ-48 · h=904 2023Q4: Δ+75 · h=979 2024Q1: Δ+56 · h=1035 2024Q2: Δ-33 · h=1002 2024Q3: Δ-111 · h=891 2024Q4: Δ+58 · h=949 2025Q1: Δ-18 · h=931 2025Q2: Δ+10 · h=941 2025Q3: Δ-28 · h=913 2025Q4: Δ+7 · h=920 2026Q1: Δ+34 · h=954 2018Q1: holders=277 2018Q2: holders=290 2018Q3: holders=361 2018Q4: holders=415 2019Q1: holders=454 2019Q2: holders=418 2019Q3: holders=426 2019Q4: holders=510 2020Q1: holders=592 2020Q2: holders=718 2020Q3: holders=727 2020Q4: holders=732 2021Q1: holders=730 2021Q2: holders=723 2021Q3: holders=795 2021Q4: holders=932 2022Q1: holders=860 2022Q2: holders=798 2022Q3: holders=792 2022Q4: holders=918 2023Q1: holders=904 2023Q2: holders=952 2023Q3: holders=904 2023Q4: holders=979 2024Q1: holders=1035 2024Q2: holders=1002 2024Q3: holders=891 2024Q4: holders=949 2025Q1: holders=931 2025Q2: holders=941 2025Q3: holders=913 2025Q4: holders=920 2026Q1: holders=954 -137 -68.5 +0 +68.5 +137 2496681087 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 15 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 8% — —
2024Q4 Top 8% -3.9% -10.6%
2024Q1 Top 3% -40.9% -42.2%
2023Q4 Top 6% +12.2% -33.6%
2023Q2 Top 2% -8.8% +5.9%
2022Q4 Top 1% +1.5% -9.6%
2021Q4 Top 2% -25.4% -15.4%
2021Q3 Top 1% -36.2% -52.4%

Options Sentiment

Put holders
26
QoQ: -3
Call holders
23
QoQ: -10

See methodology →

Fundamentals

PE (TTM)
31.6
EPS (TTM)
$2.33
EPS YoY
+75.2%
Revenue (TTM)
$4.8B
Revenue YoY
+16.2%
Quarterly Revenue & EPS (4Y)
2022-06-30: $0.7B 2022-09-30: $0.8B 2022-12-31: $0.8B 2023-03-31: $0.7B 2023-06-30: $0.9B 2023-09-30: $1.0B 2023-12-31: $1.0B 2024-03-31: $0.9B 2024-06-30: $1.0B 2024-09-30: $1.0B 2024-12-31: $1.1B 2025-03-31: $1.0B 2025-06-30: $1.2B 2025-09-30: $1.2B 2025-12-31: $1.3B 2026-03-31: $1.2B 2022-06-30: EPS 0.12 2022-09-30: EPS 0.24 2022-12-31: EPS 0.23 2023-03-31: EPS 0.12 2023-06-30: EPS 0.28 2023-09-30: EPS 0.29 2023-12-31: EPS 0.61 2024-03-31: EPS 0.36 2024-06-30: EPS 0.35 2024-09-30: EPS 0.34 2024-12-31: EPS 0.37 2025-03-31: EPS 0.27 2025-06-30: EPS 0.45 2025-09-30: EPS 0.70 2025-12-31: EPS 0.67 2026-03-31: EPS 0.51 0B 0.6B 1.3B $B 0.00 0.39 0.77 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 63 2023-03-31: PE 1672023-06-30: PE 127.82023-09-30: PE 113.92023-12-31: PE 902024-03-31: PE 85.32024-06-30: PE 46.42024-09-30: PE 45.72024-12-31: PE 62.72025-03-31: PE 64.32025-06-30: PE 56.62025-09-30: PE 32.42025-12-31: PE 33.52026-03-31: PE 26.5 24 100 175 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)